The study revealed unprecedented adipose tissue reduction outcomes, particularly in participants receiving the highest 12 mg dose (Jastreboff et al., 2023): 24.2% average adipose tissue reduction at 48 weeks (~26.2 kg or 57.8 lbs)
Bone density loss may be associated with long-term GLP-1 use, although findings are still inconclusive
3.3 Intestinal microecological imbalance in PCOS The gastrointestinal tract (GI) is inhabited by trillions of microorganisms, including bacteria, archaea, fungi, and viruses
In binge eating disorder, however, these episodes go beyond sporadic emotional eating they are more frequent, more distressing, and often feel impossible to control
A review of the current status of biological effects of plant-derived therapeutics in breast cancer
It has shown significant promise as an effective intervention against type 2 diabetes (T2D) and excessive body weight, resulting in the United States Food and Drug Administration (FDA) approving its use against both conditions in May 2022 for T2D and November 2023 for obesity
